Healthy Skepticism’s new AdWatch: understanding drug promotion

Mansfield, Peter R

doi:10.5694/j.1326-5377.2003.tb05730.x

Topics

The AdWatch section of the Healthy Skepticism website (www.healthyskepticism.org/adwatch.asp) aims to improve medical decision-making by illuminating the techniques used in drug advertising. AdWatch draws on 20 years of dialogue about drug promotion plus ideas from many disciplines, especially logic, psychology and marketing.

Healthy Skepticism Inc, Willunga, SA.

Correspondence:

Acknowledgements:

AdWatch is based on an original suggestion from general practitioner Danny Csutoros. Its design was influenced by a survey of our subscribers, the Media Watch TV program and experiences with MaLAM and our Healthy Scepticism New Zealand newsletter.

Competing interests:

I have occasionally received payment for time from Healthy Skepticism Inc.

1. Dukes MN. Accountability of the pharmaceutical industry. Lancet 2002; 360: 1682-1684.
2. Lexchin J, Mansfield PR, Mintzes B, et al. Drug promotion database. World Health Organization Department of Essential Drugs and Medicines Policy, Health Action International Europe and Universiti Sains Malaysia. Available at: www.drugpromo.info (accessed Oct 2003).
3. Sweet M. Website launched to expose “tricks” of drug ads. BMJ 2003; 327: 936.
4. Mansfield PR. MaLAM, a medical lobby for appropriate marketing of pharmaceuticals. Med J Aust 1997; 167: 590-592. <MJA full text>
5. Mansfield PR. Classifying improvements to drug marketing and justifications for claims of efficacy. Int J Risk Safety Med 1991; 2: 171-184.
6. Vlassov V, Mansfield PR, Lexchin J, Vlassova A. Do drug advertisements in Russian medical journals provide essential information for safe prescribing? West J Med 2001; 174: 391-394.
7. Mansfield PR, Lexchin J, Vitry A, et al. Drug advertising in medical journals. Lancet 2003; 361: 879.
8. Garai PR. Advertising and promotion of drugs. In: Talalay P, editor. Drugs in our society. Baltimore: Johns Hopkins Press, 1964.
9. Hamblin CL. Fallacies. London: Methuen, 1970.
10. Scott DK, Ferner RE. “The strategy of desire” and rational prescribing. Br J Clin Pharmacol 1994; 37: 217-219.
11. Sutherland M. Advertising and the mind of the consumer: what works, what doesn’t and why. Sydney: Allen and Unwin, 1993: 189-202.
12. Popkin RH. The history of scepticism: from Erasmus to Descartes. New York: Harper Torchbooks, 1964.
13. Hurtt RK. Skeptical about skepticism: instrument development and experimental validation [dissertation]. Salt Lake City, Utah: University of Utah, 1999.
14. Kahneman D, Slovic P, Tversky A. Judgment under uncertainty: heuristics and biases. New York: Cambridge University Press, 1982.
15. Sagarin BJ, Cialdini RB, Rice WE, Serna SB. Dispelling the illusion of invulnerability: the motivations and mechanisms of resistance to persuasion. J Pers Soc Psychol 2002; 83: 526-541.
16. A review of new drugs and indications in 2002: financial speculation or better patient care? Prescrire Int 2003; 12: 74-77.
17. Wilkes MS, Hoffman JR. An innovative approach to educating medical students about pharmaceutical promotion. Acad Med 2001; 76: 1271-1277.

Online responses are no longer available. Please refer to our instructions for authors page for more information.